Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Medline Inc, CL-A stake
total: 670
Viking Global Investors MDLN trades
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2025 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen holds 4,841,080 Medline Inc, CL-A (MDLN) shares with a market value of roughly $190.93M accounting for 0.54% of the overall portfolio. To date, the estimated cost basis is nearly $42.98 for "buy" trades and estimated average "sell" price is $39.44. Viking Global Investors first purchased MDLN in 2025 Q4, initially acquiring about 6.96M shares. Since the initial investment in Medline Inc, CL-A (MDLN), Viking Global Investors has made 2 more transactions.
When did Ole Andreas Halvorsen buy Medline Inc, CL-A (MDLN)?
Ole Andreas Halvorsen first invested in Medline Inc, CL-A (MDLN) in 2025 Q4 at the reported quarter-end price of $42.00 per share.
What's the cost basis of Viking Global Investors's MDLN stake?
The estimated cost basis for Medline Inc, CL-A (MDLN) stake is around $42.98 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $42.98
- Weighted AVG sell price:
- $39.44
Ole Andreas Halvorsen's historical trades in Medline Inc, CL-A
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.54%
|
4,841,080
|
$39.44
|
$190,932,195
|
-57.66% (-6,592,912)
|
-0.73%
|
|
2026 Q1
|
1.42%
|
11,433,992
|
$44.50
|
$508,812,644
|
+64.30% (+4,474,835)
|
+0.56%
|
|
2025 Q4
|
0.78%
|
6,959,157
|
$42.00
|
$292,284,594
|
new
|
+0.78%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.